chromosome

trends & perspectives in clinical research

goBalto Chromosome

Stop Rolling the Dice in Site Selection

by Craig Morgan
25Jul2016

Alarmingly, an "adverse" event with a selected site is more likely than rolling a 7 in the dice game of craps. The "Lucky 7" denotes gambler's luck and is statistically the most likely number to roll. Selecting the 'right' site to enroll patients is critical to the overall cost and duration of a trial, a process that continues to stymie the industry.

read more

Breakthroughs in Clinical Trials Utilizing the Power of the Cloud

by Craig Morgan
18Jul2016

Clinical trials play an essential role in the drug development process by effectively demonstrating the efficacy and safety of a pharmaceutical compound. Although lead by scientific endeavor with patient safety and therapeutic benefits in mind, the process of bringing drugs to market is long, complex, bureaucratic and, above all else, expensive.

read more

Webinar: The last Major Frontier in Automating Clinical Operations - Study Startup

by Craig Morgan
14Jul2016

Save your seat for this upcoming webinar! There has been a strong focus on study conduct, but as stakeholders are increasingly aware that better SSU processes are linked to shorter clinical timelines, the emphasis is shifting in that direction.

read more

Innovation Detractors in Pharma

by Sujay Jadhav
11Jul2016

In most industries, the pace of technology change has increased so much that corporate IT leaders who don't embrace emerging trends end up behind the competition and eventually out of business. Can we really say the same is true for pharma companies?

read more

How Can You Make Site Identification And Activation More Efficient?

by Ed Miseta
05Jul2016

Site activation in clinical trials is not an efficient process. Those inefficiencies delay the start of trials and are costly to sponsors, CROs, and sites. But more importantly, they keep medicines from getting to patients in a timely manner.

read more

What Ebola can Teach us about Adaptive Trial Design

by Sujay Jadhav
27Jun2016

Evaluating the efficacy of novel therapeutics in the context of epidemics is challenging to say the least, with situations evolving rapidly and heighten ethical concerns about research during public health emergencies.

read more

Clinical Trials and the Power of the Cloud

by Craig Morgan
20Jun2016

Clinical trials are horrible things, according to a recent article in TechTarget. Although lead by scientific endeavor with patient safety and therapeutic benefits in mind, the process of bringing drugs to market is long, complex, bureaucratic and, above all else, expensive.

read more

Come see goBalto at DIA 2016

by Jae Chung
16Jun2016

The DIA Annual Meeting, Philadelphia, PA (June 26-30), is the largest multidisciplinary event of its kind bringing together a global network of life sciences professionals.

read more

Integrated Workflows: The Unsexy Plumbing of Clinical Trials

by Craig Morgan
13Jun2016

Technology has been transforming many sectors of the economy and now it is poised to address one of the most manual, error prone, complex, bureaucratic, and, above all else, expensive bottlenecks in the pursuit of new disease treatments—clinical trials.

read more

Improving Site Selection: Taking off the Blinders

by Craig Morgan
09Jun2016

The pharmaceutical industry continues to face a never-ending onslaught of demands from stakeholders demanding greater clinical trial transparency and regulatory exemptions stemming from growing concerns over costs and lengthy delays in trials, as healthcare costs spiral upwards and patients continue to wait for life saving therapies.

read more

Webinar: Driving informed decisions in site selection - It's a two-way street

by Craig Morgan
06Jun2016

Save your seat for this upcoming webinar! Risk based site selection is like an informed consent, you need the right information to make the best decision.

read more

Bringing Transparency and Collaboration to CRO Oversight

by Craig Morgan
31May2016

The connection between sponsors and contract research organizations (CROs) is strengthening as outsourcing continues to be a clinical trial mainstay. Making the relationship between the sponsor and the CRO as productive as possible means acknowledging the ongoing transition away from tactical projects and toward strategic partnerships, with both stakeholders having a vested interest.

read more

Going Virtual: Changing the Clinical Trial Landscape

by Sujay Jadhav
26May2016

Imagine its 2025. Participating in a clinical trial does not require travel to a clinical research facility or doctor's office. Your mobile device (maybe a phone, watch, or even your glasses) is your link to the clinical research study and where you report general information and adverse events.

read more

Reducing Study Rescue: The Importance of Getting Clinical Trials Off to a Good Start

by Craig Morgan
23May2016

Clinical trials are not for the faint of heart. Conducting even one clinical trial is a monumental task with complex processes and issues that can surface and derail a study's timeline. As a result, delays in regulatory filing, market entry, and ultimately, the delivery of new therapies to patients are all too common.

read more

Refocusing on Risk Mitigation in Starting Clinical Trials

by Jae Chung
16May2016

Both the FDA and EMA state that risk-based methodologies should begin at the start of a trial, yet in reality most risk management efforts in drug development have focused on post-marketing safety.

read more

Webinar: The Role of Transparency in CRO-Sponsor Partnerships - Enabling Better Collaboration Models

by Craig Morgan
12May2016

Save your seat for this upcoming webinar! Relationships between sponsors and contract research organizations (CROs) are getting stronger—The connection between sponsors and CROs is strengthening as outsourcing continues to be a clinical trial mainstay.

read more

From “Muddling Through” to Innovating: Driving Adoption of Technology to Improve Efficiency in Clinical Trials (Part 2)

by Sujay Jadhav
09May2016

In my last blog, I talked about innovation detractors & resistance to change in Pharma. But, just how rational are organizations when they make decisions? This blog is the second part of a two part series.

read more

Innovation Detractors & Resistance to Change in Pharma: The Elimination of FUD (Part1)

by Sujay Jadhav
02May2016

Innovation is a critical ingredient for companies striving to sustain an advantage in the increasingly competitive global marketplace. Simply "doing the same thing better" is not enough.

read more

Optimizing Clinical Studies

by Jae Chung
28Apr2016

Pharmaceutical companies are constantly looking to innovate and perform business operations in smarter ways, as the costs of drug development have continued to escalate.

read more

Automating eTMF Generation in a Multi-Partner Ecosystem

by Rob Wynden
25Apr2016

Many sponsors outsource a majority of their clinical trial activities to one or more contract research organizations (CROs). This strategy enables companies to leverage specialized expertise and take advantage of flexible resourcing, while minimizing the costs of recruiting experts, building a team and maintaining the necessary infrastructure.

read more

Invitation to MCC Feasibility/Study Startup and Risk Management/KRI meetings

by Craig Morgan
21Apr2016

You are invited to attend the MCC Feasibility/Study Start-Up and Risk Management/KRI meetings to be held in May in Princeton, NJ, Durham, NC, and Boston, MA. Please join the MCC staff and distinguished speakers for a complimentary breakfast and informative discussions.

read more

A Data Driven Approach to Site Profile Optimization

by Craig Morgan
18Apr2016

Pharma seems to be under an almost daily barrage by stakeholders wanting to see movement in the drug development statistics that have stymied the industry, and are to blame for their lackluster performance, rising healthcare costs and delays in getting much needed therapies to patients.

read more

Webinar: Tufts Report & Removing the Blinders in Site Selection

by Craig Morgan
14Apr2016

Save your seat for this upcoming webinar! Tufts CSDD presents the findings of a new study assessing practices and inefficiencies associated with site selection, study startup, and site activation in starting clinical trials.

read more

Utilization of the Crowd for Clinical Research (Part 2)

by Sujay Jadhav
11Apr2016

In my last blog, I suggested utilization of the crowd for funding of clinical research. This blog is the second part of a two part series.

read more

goBalto Awarded Top 20 Most Promising Biotech Technology Solution Providers by CIOReview Magazine

by Craig Morgan
07Apr2016

Industry proven study startup process optimization key to selection.

read more

Utilization of the Crowd for Clinical Research (Part 1)

by Sujay Jadhav
04Apr2016

Recent studies have estimated the cost to bring a new drug to market ranges somewhere between $161 million and $2 billion, and these costs are rising rapidly. This blog is the first part of a two part series.

read more

goBalto Delivers First End-to-End Study Startup Platform for Clinical Trials

by Craig Morgan
31Mar2016

With this mornings release of goBalto Select for site profile optimization, goBalto becomes the first life science software vendor to offer a complete end-to-end platform for starting clinical trials, from site feasibility assessment and selection through to activation, with comprehensive metrics to track adherence to timelines and budget.

read more

Risk Mitigation Pivotal to Starting Clinical Trials

by Craig Morgan
28Mar2016

While most of the industry's risk management efforts have focused on post-marketing drug safety, the clinical trial process holds a broad array of other potential risks that could jeopardize a company's multi-million-dollar product development investment—risks such as site staffing shortages, patient recruitment issues, logistical problems with drug supplies, or regulatory delays.

read more

Rethinking "Patient Centricity"

by Sujay Jadhav
24Mar2016

The drug development community is increasingly turning to patient engagement or "patient centricity" approaches to optimize clinical trials costs and improve research outcomes.

read more

Webinar: New Tufts CSDD Study on Site Selection and Initiation

by Craig Morgan
21Mar2016

Save your seat for this upcoming webinar! Tufts CSDD presents the findings of a new study assessing practices and inefficiencies associated with site selection, study startup, and site activation in starting clinical trials.

read more

goBalto Named Clinical Research & Excellence Awards Finalist

by Craig Morgan
18Mar2016

The Clinical and Research Excellence Awards recognize goBalto's Activate solution in the 'Best Sponsor-Focused Technological Development' category.

read more

Better Study Startup Means Less Study Rescue

by Craig Morgan
14Mar2016

When a clinical trial does not unfold as planned, it may be heading for rescue. Communication problems among stakeholders, patient enrollment delays, overly complex protocols, and poor site compliance are just a few of the many reasons why rescue action is needed.

read more

goBalto Partners with Metrics Champion Consortium to Define Benchmarking Metrics for Study Startup

by Jae Chung
10Mar2016

As a member of the Leadership Group, goBalto and the Metrics Champion Consortium member organizations will collaborate to define industry benchmark measures for organizations engaged in starting clinical trials.

read more

Barriers to Big Data Innovation in Healthcare

by Sujay Jadhav
07Mar2016

In the last several years, we have seen tremendous advances in the amount of data we routinely generate and collect, as well as our ability to analyze and understand it. The intersection of these trends is what we call "Big Data" and it is helping businesses in every industry to become more efficient and productive.

read more

Speeding Study Startup Through Better Collaboration and Data Flow

by Barry Milton
29Feb2016

A critical question facing many sponsors and contract research organizations (CROs) is whether another system to support study startup (SSU) is really needed.

read more

BI the Way

by Craig Morgan
22Feb2016

The potential of eClinical technologies can be optimized through the use of cloud-based tools for analyzing business intelligence, with actionable visual reports helping to identify study bottlenecks and improve performance.

read more

Q&A: Bringing Order to Sponsor Oversight

by Ron Rosenberg
15Feb2016

CenterWatch editor interviews Jae Chung, goBalto's President and Founder on vendor oversight.

read more

Risk mitigation key to successful Study Startup

by Craig Morgan
08Feb2016

While most of the industry's risk management efforts have focused on post-marketing drug safety, the clinical trial process holds a broad array of other potential risks that could jeopardize a company's multi-million-dollar product development investment—risks such as site staffing shortages, patient recruitment issues, logistical problems with drug supplies, or regulatory delays.

read more

Accelerating Clinical Trials From the Outset

by Craig Morgan
01Feb2016

With thousands of investigational pharmaceuticals, biologics, and medical devices in clinical trials, there is intense pressure to speed them along so the more promising candidates will come to market sooner.

read more

goBalto selected by Tech TrailBlazer for Cloud Innovation

by Craig Morgan
27Jan2016

goBalto has been shortlisted as a finalist for the Tech Trailblazers Award in cloud computing category in recognition of it efforts to accelerate clinical trials.

read more

The Achilles Heel of Study Startup: Bottlenecks

by Craig Morgan
25Jan2016

The clinical trial phase of a drug development program is by far the most costly, risky, and protracted phase of the investigative process.

read more

goBalto goes for Speed by Reducing Manual Processes in Study Startups

by Melissa Fassbender
18Jan2016

Study startup times can stifle clinical trials, but automating certain processes can help eliminate costly bottlenecks.

read more

Study Startup: New Battleground in CRO Differentiation Strategy

by Craig Morgan
11Jan2016

The drug development process is long, arduous, and costly, driving many sponsors to consider greater use of contract research organizations (CROs). This move reflects sponsors' sharper focus on core competencies and the shifting of management and conducting of clinical trials to CROs.

read more

Disruptive Technologies: Breaking Down Barriers to Drug Development

by Sujay Jadhav
04Jan2016

During the last several decades, the pharmaceutical industry has delivered a multitude of life-saving medicines, creating new treatment options for a variety of unmet medical needs.

read more

Stumbling seven times but recovering eight (Part 2)

by Jae Chung
28Dec2015

Insights for Pharma Executives Sourcing Global Clinical Trials in the US and Japan. This blog is the second part of a two part series.

read more

Stumbling seven times but recovering eight (Part 1)

by Jae Chung
21Dec2015

Insights for Pharma Executives Sourcing Global Clinical Trials in the US and Japan. This blog is the first part of a two part series.

read more

"Rescue" studies: The importance of getting clinical trials off to a good start

by Craig Morgan
14Dec2015

Clinical trials are not for the faint of heart, conducting even one clinical trial is a monumental task. Many issues can arise during the course of a clinical trial that can negatively affect a study timeline, which in turn delays regulatory filing, and can ultimately delay market entry.

read more

goBalto chosen by ICON for all global studies

by Jae Chung
09Dec2015

goBalto Activate chosen by ICON for global site activation, automation and process improvement. ICON implements Activate to accelerate study startup by reducing manual processes.

read more

10 reasons you'll fall short using Excel for clinical trials

by Craig Morgan
07Dec2015

Regrettably, Excel is still omnipresent in clinical research.

read more

Challenges to patient data anonymization

by Sujay Jadhav
30Nov2015

In my last blog, I suggested that data anonymization for secondary use is potentially a major barrier to leveraging Big Data from clinical trials.

read more

Is HIPAA a barrier to Big Data in Biomedical Research?

by Sujay Jadhav
23Nov2015

The vast amount of data generated each day in healthcare represents numerous opportunities to enable the life science research community to access, manage, and implement big data.

read more

Effective differentiation, the competitive edge for CROs in Study Startup

by Craig Morgan
16Nov2015

Many sponsors are soliciting the services of CROs that employ process-driven clinical research methods. Designed to help achieve more predictable costs and actionable results, CROs employing these methods are speeding the R&D process, while reducing trial risks.

read more

Global Study Startup Survey Reveals Majority of Life Science Companies Lack Automated Processes

by Sujay Jadhav
12Nov2015

Industry leaders are adopting ‘best of breed’ applications in eClinical stack to speed clinical trials.

read more

Sponsor seeks compatible CRO: Improving Oversight

by Craig Morgan
09Nov2015

Sponsors are embracing outsourcing of clinical trials to contract research organizations (CROs) in order to contain operational and infrastructure costs, as well as gain access to therapeutic and clinical trial expertise, with the potential to complete projects better, faster and more efficiency.

read more

How pharma can fix its drug development woes by taking a page from the digital marketing playbook

by Sujay Jadhav
05Nov2015

Drug companies should leverage lessons from digital marketing to solve a big, lesser-known issue in drug development.

read more

Powerful visualizations empower business intelligence in Clinical Trials

by Craig Morgan
02Nov2015

According to a recent article in TechTarget, clinical trials are horrible things. Although Biopharma is lead by scientific endeavor, and only has patient safety and therapeutic benefits in mind, the process of bringing drugs to market is long, complex, bureaucratic and, above all else, expensive.

read more

The Need for Expediency in European Clinical Trials

by Craig Morgan
29Oct2015

New European clinical trial regulations aim to reduce administrative burden and costs. goBalto's "smart" workflows harmonize clinical trial expediency and compliance, creating an environment that is favorable for conducting clinical trials across the European Union.

read more

Unmasking Study Startup knockoffs: Big on promise, short on delivery

by Craig Morgan
26Oct2015

Is your study startup (SSU) solution masquerading as a purpose-built application? Often disguised as wolves in SSU clothing, SSU knockoffs fail to live up to expectations.

read more

Webinar: Ready to start your clinical trial? Think again.

by Craig Morgan
22Oct2015

Save your seat for this upcoming webinar! Listen to our panel of industry experts talk about the importance of getting clinical trials off to a strong start and have your questions answered.

read more

Role based document exchange facilitates efficient process optimization

by Craig Morgan
19Oct2015

In a previous blog post "The importance of Standard Operating Procedures (SOPs) in clinical trials" the automation of SOPs for document exchange for managing compliance obligations, amongst other performance benefits, was discussed.

read more

Country specific regulatory workflows streamline clinical operations & compliance

by Craig Morgan
12Oct2015

According to a recently released report from Research and Markets by 2020 the average clinical trial outsourcing penetration will likely reach around 72%. Although there are obvious benefits to outsourcing, it creates new challenges around quality, oversight, collaboration, and governance.

read more

Accelerating clinical trial startup with latest goBalto Activate release

by Jae Chung
06Oct2015

Industry standard in study startup adds robust team management and submission planning features. The third major release of 2015 offers new features that further accelerate clinical study startup.

read more

The importance of Standard Operating Procedures (SOPs) in clinical trials

by Craig Morgan
05Oct2015

Standard Operating Procedures (SOPs) are one of the most useful systems to help improve the efficiently of clinical trials, which can aptly be described as "writing down what you do, and do what is written down." 

read more

Q&A: Mush, you huskies!

by Lloyd Dunlap
28Sep2015

Drug Discovery News editor interviews Sujay Jadhav, goBalto's CEO on the company, products and future plans.

read more

Go and Balto steal the show at DPharm

by Craig Morgan
21Sep2015

The 5th Annual Disruptive Innovations to Advance Clinical Trials (September 10-11) conference is the definitive event for innovators in the clinical trial space. The entire conference introduces novel and bold approaches to help attendees think differently about how we do clinical trials.

read more

Expediting Study Startup Across the Globe

by Craig Morgan
14Sep2015

The need for more efficient clinical trials is driving greater use of cloud-based solutions, especially with the rise in globalization, a trend that is seeing participating sites venturing full force into regions such as Eastern Europe, Latin America and Asian countries. But this opportunity is not without its challenges.

read more

CTMS - a poor choice for study startup

by Rob Wynden
08Sep2015

There's no doubt that a clinical trial management system (CTMS) is vital to the clinical trial process. Primarily focusing on study execution, CTMS solutions are meant to manage all aspects of the trial process; they're built to be all encompassing. But over time clinical trials have become too complex for one single system to handle.

read more

E-Signatures: The Unsung Hero of Clinical Trial Expediency

by Pem Guerry
04Sep2015

As Craig Morgan recently pointed out in this two-part series, there is a critical and undeniable need for speed in clinical trials. E-signatures are an important step towards the automation of clinical trials.

read more

goBalto joins Society for Clinical Research Sites as Global Impact Partner

by Craig Morgan
31Aug2015

Partnership bolsters collaboration with clinical research sites.

read more

Excel: If all you have is a hammer, everything looks like a nail

by Craig Morgan
24Aug2015

The life sciences industry has recognized study startup as one of the worst performing areas in clinical trials—it is a bottleneck at the outset that slows drug development, leading to significant delays and costs.

read more

Opening Pandora's box: The transparency of Clinical Trial data

by Barry Milton
17Aug2015

The pharmaceutical industry has been on the defensive against the escalating cost of medicines, ethical issues associated with globalization of clinical trials, and access to new innovative treatments.

read more

Technology trends impacting Clinical Trials

by Ed Miseta
10Aug2015

I have written several articles recently about companies in the pharma industry that continue to use paper for clinical trials when technology now exists to make all of it obsolete. 

read more

Are you an industry leader or a laggard in Study Startup?

by Craig Morgan
05Aug2015

Advanced, cloud-based collaboration platforms allow sponsors, CROs, and sites to dramatically reduce study startup timelines, eliminate bottlenecks, and reduce costs.

read more

The need for speed in Study Startup (Part 2)

by Craig Morgan
27Jul2015

Streamlining SSU

The clinical trial landscape is ripe for bringing substantial improvements to the SSU process.

read more

The need for speed in Study Startup (Part 1)

by Craig Morgan
20Jul2015

The status of clinical trials continues to stymie industry stakeholders anxious to rein in the cost of product development and adhere to tighter timelines. 

read more

New release of goBalto Activate enhances risk management in Clinical Trials

by Jae Chung
13Jul2015

Industry standard in clinical study startup adds robust project management and business optimization features

read more

goBalto triples sites managed, further reinforcing market leadership position

by Jae Chung
06Jul2015

Rapid adoption of award winning study startup solutions drive market penetration in Life Sciences industry

read more

Become a disruptive leader in Clinical Trials and lead the competition

by Craig Morgan
30Jun2015

The life sciences industry has recognized study startup as one of the worst performing areas in clinical trials. Many organizations struggle to control costs and resources associated with ramping up clinical trials. 

read more

Traversing the user journey

by Tammy Coombs
24Jun2015

In a previous blog post, Usability in action, I discussed conducting interviews and usability sessions to understand your users' needs, and how to use these tools to develop your designs. But wait, there's more—or, there are steps to take before moving on to usability.

read more

goBalto congratulates the DIA prize winners

by Jae Chung
22Jun2015

The DIA Annual Meeting, held recently in Washington D.C. (June 14-18), is the largest multidisciplinary event of its kind bringing together a global network of life sciences professionals.

read more

How to conduct a successful usability session

by Tammy Coombs
15Jun2015

We've all heard the saying, "test early and test often." When I first began doing usability testing, I was scared to death. I cowered behind my designs, wanting to test later and test seldom. Why?

read more

Speeding Clinical Trials Through eClinical Systems

by Elvin Thalund
11Jun2015

Testing the safety and efficacy of new drugs is a costly and complex process for pharmaceutical organizations. The rising cost and complexity compromises profitability and can stifle research and innovation.

read more

Collaboration is the keystone as the pace of outsourced Clinical Trials accelerates

by Craig Morgan
08Jun2015

Clinical Research Organizations (CRO) that specialize in clinical trials offer sponsors the expertise of moving a new drug or device from its conception to FDA marketing approval, without the sponsor having to incur costs associated with staffing these services.

read more

Trusted Collaboration

by Sandra Freeman
04Jun2015

Outsourcing different aspects of the clinical study process is a growing trend; 64 percent of trials are currently outsourced. Of those that don't currently, 54 percent plan to outsource in the future, according to a survey conducted by Clinical Informatics News.

read more

The Achilles heel of clinical trial study startup—Bottlenecks

by Craig Morgan
01Jun2015

Over the past decade the capitalized cost to develop an approved new drug has more than doubled from $1,044M in 2003 to $2,558M in 2013 (source: CSDD, 2015).

read more

An attitude for CAN

by Craig Morgan
28May2015

We bring significant technological disruptions to the historically inefficient and error prone startup stages in clinical trials inspite of being told by industry veterans that, "you can't bring standards to study startup because of regulatory complexities, people's tendencies to not change, and that people have tried before, etc."

read more

Moving beyond simple APIs in the eClinical Stack

by Craig Morgan
26May2015

True integration is critical to plug and play coexistence

goBalto is the only non-TMF vendor to have released a fully integrated framework based on the new DIA TMF reference model (version 3.0) XML-based exchange mechanism (see "A new eTMF Exchange Initative: Presentation at the DIA eRegulatory and Intelligence Conference" by Paul Fenton, chair of DIA TMF reference model V3 Exchange Group).

read more

Globalization of clinical trials increases complexity in oversight

by Craig Morgan
21May2015

As clinical trials increasingly are conducted outside the US, Pharma and CROs face both opportunity and challenge especially in emerging markets.

read more

Gartner recognizes goBalto as a "Cool Vendor in Life Sciences"

by Craig Morgan
19May2015

Vendors selected for the "Cool Vendor" report are innovative, impactful and intriguing. Gartner's Cool Vendor research "is designed to highlight interesting, new and innovative vendors, products and services."

read more

Eliminating the three evil "e's" from Study Startup

by Craig Morgan
15May2015

Study startup is the process of (i) identifying and (ii) activating investigative sites. Historically, the study startup phase has been viewed as inherently inefficient and error prone—the workhorse of clinical trials being labor intensive, costly, and time-consuming.

read more

For faster study startup eTMF alone won't cut it

by Rob Wynden
08May2015

There's no doubt that a electronic trial master file (eTMF) is vital to the clinical trial process, to comply with regulatory requirements by securely maintaining and storing essential trial documents.

read more

What differentiates goBalto from an eTMF?

by Rob Wynden
02Apr2015

Before we answer this question, let's just state for the record: an eTMF is an important tool for organizing your clinical study startup documents and providing easy access to those documents. An eTMF plays a central role in the submission and closeout phase of the trials process.

read more

No, eTMF can’t do study startup – despite what you’ve heard

by Rob Wynden
19Mar2015

The question of whether existing technologies like eTMF can manage study startup often comes up when I meet with clinical trial sponsors and CROs. There’s a lot of confusion in the market about what these systems can and cannot do, for a few reasons.

read more

Using Technology to Improve Study Startup

by Roshan Padbidri
22Oct2014

SSU process improvement: a brief history

In the early days of contract research organizations (CROs), when just a handful of CROs existed, big pharma handled most of their own clinical development.

read more

Usability in Action

by Tammy Coombs
25Mar2014

In last month’s post, Steve Winter discussed the elements of effective user experience design. goBalto uX Designer Tammy Coombs highlights the people aspect of UX design and shares details of a usability visit with a goBalto partner.

read more

Designing the Experience

by Steve Winter
13Feb2014

Effective user experience (UX) design requires a deep understanding of users, what they need, what they value, and their goals and expectations of an application. We study and evaluate how people get things done, and translate this into an elegant user interface.

read more

Patient Recruitment (Again)

by Blake Reuter
22Aug2013

Yes, patient recruitment continues to be a major bottleneck in clinical research. Just as it was a decade ago, about a third (37%) of sites in a given trial still fail to reach their enrollment goals, and 11% fail to enroll any subjects at all.

read more

Investigators’ Main Complaint: Study Site Payment Schedules

by Blake Reuter
07Aug2013

The recent article Consistent Trial Site Payments Key to Long-Term Relationships with Investigators (25JUL2013) highlights that “CROs and sponsors look to retain their most highly-prized sites and establish long-term relationships for future trials.”

read more

What Are the Top Three Items Used to Select Sites? ...And What Should They Be?

by Sherry Reuter
27Mar2012

A frank discussion about studies

An interesting discussion has taken place over the last month on LinkedIn in the The Association of Clinical Research Professionals group (view discussion here).

read more

Source Document Verification - How much is enough?

by Sherry Reuter
23Feb2012

Status quo and how things are changing

Performing 100% Source Document Verification (SDV) has been the gold standard for years in clinical research. CRAs spent much of their careers checking every datapoint on CRFs against Source Data.

read more
load more